ASH News Daily - Tuesday, December 13, 2011 - (Page A-1)
Celebrating 10 Years
ASH NEWS DAILY
53rd Annual Meeting of the American Society of Hematology
®
Issue 4, Section A
Tuesday, December 13, 2011
San Diego, CA
Read this issue online at
www.nxtbook.com/nxtbooks/ashnewsdaily2011_Tuesday/
Schedule
7:30 – 9:00 a.m.
Simultaneous Sessions
7:30 – 9:00 a.m.
Late-Breaking Abstracts Session
San Diego Convention Center
Hall AB
7:30 – 9:00 a.m.
Special Symposium on the Basic
Science of Hemostasis and Thrombosis
(invited presentations)
San Diego Convention Center
Ballroom 20D
9:30 – 9:45 a.m.
Announcement of the Dameshek
Prize and the Stratton Medal
San Diego Convention Center
Hall AB
9:45 – 11:15 a.m.
Presidential Symposium
San Diego Convention Center
Hall AB
11:15 – 11:30 a.m.
Business Meeting
San Diego Convention Center
Hall AB
12:00 noon – 1:00 p.m.
Best of ASH
San Diego Convention Center
Room 20ABC
12:00 noon – 1:00 p.m.
Special Symposium on the Basic
Science of Hemostasis and Thrombosis
(simultaneous oral sessions)
San Diego Convention Center
Rooms 24, 25, 29, 30, 31, 33
IN THIS SECTION
Plausability of
Platelets in Immunity
A-2
Neutrophils
and TRALI
A-3
Bone Marrow Failure:
Success May Be on
the Horizon
A-6
Patient
Communication:
It Matters to
Them – And You
A-7
D
r. E. Donnall Thomas, a Nobel
Prize laureate, is honored
on an annual basis
at the ASH annual meeting in the
form of a Monday morning lecture.
The E. Donnall Thomas Lecture
and Prize recognizes pioneering research
achievements in hematology
that have represented a paradigm
shift or significant discovery in the
field. This year’s winner, Dr. George
Q. Daley, is world renowned for his
work in stem cell research, and yesterday
he delivered a wonderful
lecture titled “Hematopoietic, Embryonic,
and Induced Pluripotent
Stem Cells: Diseases, Myths, and
Medicines.” The lecture focused on
the promises and challenges of applying
stem cells, specifically embryonic
stem cells, to the study and
treatment of disease.
During the lecture, Dr. Daley
shared how his early research on
chronic myeloid leukemia (CML)
and BCR-ABL led to work on hematopoietic
stem cells and subsequently
to genetically modified human
BREAKING NEWS
It’s Not Too Late to Make a Break
By JoSeph Mikhael, Md, Med
T
AB of the San Diego Convention
Center. The Late-Breaking Abstract
session, a relatively new addition
to the annual meeting, is not to be
missed on the final day. This session
showcases six abstracts whose
results were only available six
weeks ago and will be sure to capture
the attention of many, as genuinely
ground-breaking data, in both
clinical and basic science fields, will
be presented.
A Norwegian randomized, con-
for Late-Breaking Abstracts
trolled trial of catheter-directed
thombolysis (CDT) in proximal
deep-vein thrombosis (The
CaVenT study) will be presented
by Dr. Tone Rønnaug Enden, Oslo
University Hospital. Post thrombotic
syndrome (PTS) remains a
serious long-term complication
of many patients who experience
a DVT. Rapid patency of the vessel
theoretically would reduce the
incidence and severity of PTS, but
very little has been done to validate
this prospectively. This study was
designed to reduce PTS by adding
CDT to standard anticoagulation.
With more than 200 patients with
acute iliofemoral DVT enrolled,
his just in … late-breaking
abstracts are about to be presented
at 7:30 a.m. in Hall
there was a significant reduction in
PTS in patients who received CDT.
This, however, comes at the cost of
increased bleeding, including major
bleeding episodes. Come find
out more about who may best benefit
from this procedure.
Lymphoma biology will also
be highlighted in the session. Dr.
Aurelien Marabelle, Stanford University,
will present fascinating
data on the role of regulatory T
cells (Tregs) and how they may be
manipulated to enhance tumor response,
even at distant sites such
as CNS lymphoma. This unique
»» ABSTRACTS Page A-7
A Beautiful Memory of a Career
Committed to Science
By Michael R. BiShop, Md
Dr. George Q. Daley listens to his introduction as he prepares to present the E.
Donnall Thomas Lecture, “Hematopoietic, Embryonic, and Induced Pluripotent
Stem Cells: Diseases, Myths, and Medicine.”
embryonic stem cells. Dr. Daley,
who has long been a steady voice of
reason regarding embryonic stem
cell research, highlighted the overzealous
and unrealistic hype in the
earliest days of embryonic stem cell
research, succinctly took the audi-
ence through past research, and
brought us up to date on the most
recent advances in this field, including
his own work on genetically
modified human embryonic
»» E. DONNALL THOMAS Page A-7
https://www.nxtbook.com/nxtbooks/ashnewsdaily2011_Tuesday/
Table of Contents for the Digital Edition of ASH News Daily - Tuesday, December 13, 2011
ASH News Daily - Tuesday, December 13, 2011
https://www.nxtbookmedia.com